https://vision2030.ai/tags/sfda/Recent content in SFDA on SAUDI VISION 2030 Intelligence PlatformHugoenSat, 18 Apr 2026 00:00:00 +0000https://vision2030.ai/encyclopedia/saudi-pharmaceutical-manufacturing/Sun, 22 Feb 2026 00:00:00 +0000https://vision2030.ai/encyclopedia/saudi-pharmaceutical-manufacturing/<p>This Saudi pharmaceutical manufacturing KPI guide tracks localization, market scale, leading companies, regulation, and Vision 2030 industrial demand. Saudi Arabia&rsquo;s pharmaceutical manufacturing sector occupies a pivotal position at the intersection of two <a href="https://vision2030.ai/vision/">Vision 2030</a> priorities: healthcare system transformation and industrial diversification. The Kingdom is the largest pharmaceutical market in the Middle East and North Africa, with annual expenditure exceeding forty billion Saudi riyals, yet has historically imported the vast majority of its medicines. <a href="https://vision2030.ai/encyclopedia/vision-2030/">Vision 2030</a>&rsquo;s <a href="https://vision2030.ai/encyclopedia/nidlp/">National Industrial Development and Logistics Programme (NIDLP)</a> has established ambitious localisation targets that aim to transform the Kingdom from a predominantly import-dependent consumer into a regional hub for pharmaceutical research, development, and manufacturing.</p>